Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Equity Ratio (2016 - 2025)

Macrogenics (MGNX) has disclosed Equity Ratio for 14 consecutive years, with 0.22 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 51.2% to 0.22 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.22 through Dec 2025, down 51.2% year-over-year, with the annual reading at 0.22 for FY2025, 51.2% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.22 at Macrogenics, down from 0.25 in the prior quarter.
  • The five-year high for Equity Ratio was 0.8 in Q1 2021, with the low at 0.19 in Q2 2025.
  • Average Equity Ratio over 5 years is 0.5, with a median of 0.51 recorded in 2023.
  • The sharpest move saw Equity Ratio plummeted 51.55% in 2023, then surged 34.41% in 2024.
  • Over 5 years, Equity Ratio stood at 0.71 in 2021, then fell by 29.16% to 0.51 in 2022, then rose by 1.0% to 0.51 in 2023, then decreased by 13.27% to 0.44 in 2024, then tumbled by 51.2% to 0.22 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.22, 0.25, and 0.19 for Q4 2025, Q3 2025, and Q2 2025 respectively.